Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 8/20 | 0.35 |
| ▸ | PPARD | Q03181 | 4/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23895984 | 1.00 | TRPV3 (0.35) | TRPV3FFAR1PPARDPTGER2ESR1 | |
| SCHEMBL23887753 | 0.92 | FFAR1 (0.36) | FFAR1PPARDPTGER2GRIN2B | |
| SCHEMBL30121049 | 0.84 | PPARD (0.37) | FFAR1PPARDPTGER2GRIN2B | |
| SCHEMBL23887694 | 0.84 | PPARD (0.37) | FFAR1PPARDPTGER2GRIN2B | |
| SCHEMBL23887731 | 0.83 | FFAR1 (0.35) | FFAR1PPARDPTGER2GRIN2B | |
| SCHEMBL23896086 | 0.82 | FFAR1 (0.38) | FFAR1PPARDPTGER2GRIN2BGRM5 | |
| SCHEMBL25544731 | 0.81 | DHODH (0.40) | TRPV3FFAR1DHODH | |
| SCHEMBL25183696 | 0.80 | MEN1 (0.37) | FFAR1PPARD | |
| SCHEMBL23895992 | 0.79 | GCGR (0.42) | FFAR1PPARDESR1 | |
| SCHEMBL25544111 | 0.79 | PTGDR2 (0.38) | FFAR1PPARDPTGER2GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126819-A1 | 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) | Vertex Pharmaceuticals Incorporated (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-115697969-A | 7-or 8-hydroxy-isoquinoline and 7-or 8-hydroxy-quinoline derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) | 弗特克斯药品有限公司 | 2023-02-03 | — | — | CN | disclosed |